
Medicine and Health
A multimodal deep learning approach for the prediction of cognitive decline and its effectiveness in clinical trials for Alzheimer’s disease
C. Wang, H. Tachimori, et al.
This innovative study, conducted by Caihua Wang, Hisateru Tachimori, Hiroyuki Yamaguchi, Atsushi Sekiguchi, Yuanzhong Li, and Yuichi Yamashita, presents a groundbreaking AI-driven method to enhance the randomization process in Alzheimer's disease clinical trials, significantly reducing participant allocation bias and trial size. Discover how they utilized a multimodal deep learning model to predict cognitive decline accurately!
Playback language: English
Related Publications
Explore these studies to deepen your understanding of the subject.